Cellular Endocytosis and Gene Delivery
Authors:
Open Access
- 3 February 2010
- journal article
- review article
- Published by Springer Nature in Molecular Medicine
- Vol. 16 (5-6) , 222-229
Abstract
Endocytosis is the process by which cells take up macromolecules from the surrounding medium. The best-characterized process is the so-called clathrin-dependent endocytosis, although much is also currently known about clathrin-independent endocytic processes such as those involving caveolae and lipid rafts. An understanding of endocytosis and the cellular trafficking that occurs thereafter has a great deal of relevance to current molecular medicine. Gene therapy, which is presently being investigated for its therapeutic potential in treating immunodeficiency and metabolic diseases, cancer and heart disease, employs a variety of viral and nonviral vectors, which can be delivered to the target cells of the body and are subsequently endocytosed and dissembled. A variety of vectors can be used to deliver genes to organs in vivo or cells ex vivo. Various routes of vector delivery have been investigated. The mechanisms by which vectors such as adenoviruses, adeno-associated viruses, retroviruses and liposomes enter the cell are increasingly being investigated as the effort to increase the efficiency of gene therapy continues. This review focuses on mechanisms of endocytosis and how they relate to the internal trafficking of viral and nonviral vectors in gene therapy.Keywords
This publication has 79 references indexed in Scilit:
- Endocytic pathways: combined scanning ion conductance and surface confocal microscopy studyPflügers Archiv - European Journal of Physiology, 2008
- Tumor-targeted Delivery of siRNA by Self-assembled NanoparticlesMolecular Therapy, 2008
- Targeted delivery of proteins across the blood–brain barrierProceedings of the National Academy of Sciences, 2007
- Distinct Mechanisms of Clathrin-independent Endocytosis Have Unique Sphingolipid RequirementsMolecular Biology of the Cell, 2006
- Occurrence of leukaemia following gene therapy of X-linked SCIDNature Reviews Cancer, 2003
- Caveolin-1 Is a Negative Regulator of Caveolae-mediated Endocytosis to the Endoplasmic ReticulumJournal of Biological Chemistry, 2002
- The endocytic pathway: a mosaic of domainsNature Reviews Molecular Cell Biology, 2001
- Dynamin at the Neck of Caveolae Mediates Their Budding to Form Transport Vesicles by GTP-driven Fission from the Plasma Membrane of EndotheliumJournal of Cell Biology, 1998
- De novo formation of caveolae in lymphocytes by expression of VIP21-caveolin.Proceedings of the National Academy of Sciences, 1995
- Caveolin, a protein component of caveolae membrane coatsCell, 1992